MedPath

Evaluation of Treatment Methods for Clinically Significant Tinnitus

Phase 2
Completed
Conditions
Tinnitus
Registration Number
NCT00013390
Lead Sponsor
US Department of Veterans Affairs
Brief Summary

The investigators propose to evaluate two different approaches to the alleviation of tinnitus symptoms by comparing changes from baseline performance on the Tinnitus Severity Index. They propose to provide an unbiased evaluation of competing methodologies. The design is one in which pairs of prospective subjects are randomly assigned to one of two treatment groups. Changes in group performance will be compared for selected measures.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
200
Inclusion Criteria

Patients with significant tinnitus

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Tinnitus Severity IndexBaseline, 3 mo., 6 mo., 12 mo., 18 mo.

A well-developed scale currently in use at the Oregon Tinnitus Clinic.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

VA Medical Center, Portland

🇺🇸

Portland, Oregon, United States

VA Medical Center, Portland
🇺🇸Portland, Oregon, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.